RxDoctor Payments Data

Milind Panse, MD

Orthopedic Surgery · Hemet, CANPI 1457362394

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,250 of the $33,636 with a category attached, or 87.0%. 24 manufacturers reported payments, led by Maxx Orthopedics, Inc. at 59.7% of the total. Reporting peaked in 2019 at $25,430 and has fallen 94.7% since, to $1,337 in 2025. Among orthopedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,636in general payments, 2019–2025

Across 119 payments — averaging $282.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Maxx Orthopedics, Inc.$20K
  • Maxx Health Inc$10K
  • Stryker$663
  • Zimmer Biomet$621
  • Johnson & Johnson$462
  • Globus Medical$257
  • plus $1K from 18 others

What the payments were for

  • Consulting fees$29,25087%
  • Travel & lodging$4621%
  • Food & beverage$3,92412%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,636 in reported general payments places this provider in the 90th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$200,709
Medicare patients
351
Services billed
4,598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CeftriaxoneCeftriaxone Sodium69$2,225
Diclofenac Sodium104$1,976
Amitriptyline Hcl94$535
Levofloxacin25$196
Tramadol Hcl31$84
Methylprednisolone15$74
Clindamycin Hcl36$71
Meloxicam11$16

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Hemet

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →